连枷胸当代结局:ACS-TQIP 2017-2023数据更新
该回顾性研究分析ACS-TQIP 2017至2023年连枷胸患者数据,共纳入41,542例,倾向性评分匹配后19,170例。总体机械通气率29.08%、气管切开率4.99%、住院死亡率6.24%、呼吸机相关肺炎3.66%、急性呼吸窘迫综合征2.22%。与2014年Dehghan等报告相比,机械通气率从59%降至29.08%,气管切开率从21%降至4.99%,死亡率从16%降至6.24%。手术肋骨内固定患者住院死亡率低于非手术患者(3.3% vs 9.2%,p<0.01),但住院时间、ICU时间及非计划ICU入住率更高。
要点
- 连枷胸总体住院死亡率6.24%、机械通气率29.08%,较2014年报告的16%和59%显著下降。
- 手术肋骨内固定患者住院死亡率3.3% vs 非手术患者9.2%(p<0.01),但住院时间11.9 vs 7.2天、ICU时间8 vs 5天更长。
- 手术肋骨内固定患者非计划ICU入住率7.5% vs 非手术患者4.4%(p<0.01)。
- 总体气管切开率4.99%、呼吸机相关肺炎3.66%、急性呼吸窘迫综合征2.22%。
- 合并颅脑损伤或肺挫伤患者的多变量分析结果见原文结果部分。
适用人群与场景
- ACS-TQIP 2017至2023年数据库中的连枷胸患者,共41,542例,倾向性评分匹配后19,170例。
研究设计与关键结果
- 研究类型:回顾性研究,分析ACS-TQIP 2017至2023年连枷胸患者数据;采用倾向性评分匹配比较手术肋骨内固定与非手术患者的临床结局,多变量分析比较合并颅脑损伤或肺挫伤患者的结局。
- 主要终点为住院死亡率;次要终点包括机械通气、住院时间和ICU时间、肺炎、脓毒症和气管切开率。
- 共识别41,542例连枷胸患者,匹配后19,170例。
- 总体结局:机械通气29.08%、气管切开4.99%、住院死亡率6.24%、呼吸机相关肺炎3.66%、急性呼吸窘迫综合征2.22%。
- 手术肋骨内固定患者住院死亡率3.3% vs 非手术患者9.2%(p<0.01),手术组更低。
- 手术肋骨内固定患者住院时间11.9 vs 非手术患者7.2天(p<0.01),手术组更长。
- 手术肋骨内固定患者ICU时间8 vs 非手术患者5天(p<0.01),手术组更长。
- 手术肋骨内固定患者非计划ICU入住率7.5% vs 非手术患者4.4%(p<0.01),手术组更高。
证据类型、等级与局限
- 证据类型:回顾性研究,证据等级Level III(预后/流行病学)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 与Dehghan等(2014)相比,本分析显示机械通气率从59%降至29.08%、气管切开率从21%降至4.99%、死亡率从16%降至6.24%,作者认为这些 morbidity 和 mortality 的下降反映了十年来连枷胸创伤中优化的重症监护和标准化管理。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Flail chest represents one of the most severe forms of blunt thoracic injury and is associated with significant morbidity and mortality. Much of the understanding of flail chest epidemiology, and outcomes came from Dehghan et al. (2014). Since then, flail chests management has undergone substantial evolution. Given these changes, we sought to examine the outcomes of flail chest that accurately reflects current clinical practice.
METHODS: This is a retrospective study analyzing the American College of Surgeons Trauma Quality Improvement Program (ACS-TQIP) 2017 to 2023 data on flail chest patients. Propensity-score matching was performed to compare clinical outcomes in patients SSRF versus no SSRF. Multivariable analysis was performed to compare the outcome of flail chest patients with concomitant head injury or pulmonary contusion. Our primary outcome is in-hospital mortality, with mechanical ventilation, hospital and Intensive Care Unit (ICU) length of stay (LOS), and the rate of pneumonia, sepsis, and tracheostomy.
RESULTS: A total of 41,542 patients with flail chests were identified, 19,170 after matching. Overall, 29.08% required mechanical ventilation, 4.99% tracheostomy, 6.24% in-hospital mortality, 3.66% VAP incidence, and 2.22% ARDS. SSRF patients had a significantly lower rate of in-hospital mortality compared with nonoperative patients (3.3% vs. 9.2%, p<0.01). However, SSRF was associated with a longer hospital LOS (11.9 vs. 7.2 days, p<0.01), ICU LOS (8 vs. 5 days, p<0.01), and higher rate of unplanned ICU admission (7.5% vs. 4.4%, p<0.01) in flail chest patients.
CONCLUSIONS: Compared with Dehghan et al. (2014), our analysis demonstrates significant improvements: mechanical ventilation rate decreased from 59% to 29.08%, tracheostomy from 21% to 4.99%, and mortality from 16% to 6.24%. These reductions in morbidity and mortality reflect a decade of optimized critical care and standardized management in flail chest trauma. (J Trauma Acute Care Surg 2026;00:000-000 Copyright © 2026 Wolters Kluwer Health, Inc. All rights reserved.).
LEVEL OF EVIDENCE: Level III (Prognostic/ Epidemiological).
参考来源
- Gabriel L, Ramesh H, Amarasinghe R, et al. Contemporary outcomes of flail chest injuries: An update from ACS-TQIP (2017-2023). J Trauma Acute Care Surg. 2026. PMID: 42296258. doi:10.1097/TA.0000000000005097
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。